Literature DB >> 10155602

Cost effectiveness of alternative hepatitis A immunisation strategies.

E van Doorslaer1, G Tormans, P van Damme, P Beutels.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 10155602     DOI： 10.2165/00019053-199508010-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  11 in total

1.  Cost-effectiveness analysis of hepatitis A prevention in travellers.

Authors:  G Tormans; P Van Damme; E Van Doorslaer
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Hepatitis A.

Authors:  A J Tilzey; J E Banatvala
Journal:  BMJ       Date:  1991-06-29

3.  Cost effectiveness of hepatitis A prevention in France.

Authors:  C A Severo; F Fagnani; A Lafuma
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

4.  Public health control of hepatitis A: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

5.  Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity.

Authors:  P Van Damme; C Matheï; S Thoelen; A Meheus; A Safary; F E André
Journal:  J Med Virol       Date:  1994-12       Impact factor: 2.327

6.  Cost-effectiveness analysis of vaccination against hepatitis A in travellers.

Authors:  E Van Doorslaer; G Tormans; P Van Damme
Journal:  J Med Virol       Date:  1994-12       Impact factor: 2.327

7.  Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers.

Authors:  R H Behrens; J A Roberts
Journal:  BMJ       Date:  1994-10-08

8.  Recommendations for Prevention of Hepatitis A Based on a Cost-Effectiveness Analysis.

Authors: 
Journal:  J Travel Med       Date:  1994-09-01       Impact factor: 8.490

9.  Epidemiology and prevention of hepatitis A in travelers.

Authors:  R Steffen; M A Kane; C N Shapiro; N Billo; K J Schoellhorn; P van Damme
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272

10.  Should British soldiers be vaccinated against hepatitis A? An economic analysis.

Authors:  T O Jefferson; R H Behrens; V Demicheli
Journal:  Vaccine       Date:  1994-11       Impact factor: 3.641
View more
  1 in total

Review 1.  Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.

Authors:  Philippe Beutels; W John Edmunds; Fernando Antoñanzas; G Ardine De Wit; David Evans; Rachel Feilden; A Mark Fendrick; Gary M Ginsberg; Henry A Glick; Eric Mast; Marc Péchevis; Eddy K A Van Doorslaer; Ben A van Hout
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.